PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28928082-0	2017	miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.	Fluorouracil	19-33	tumor protein p53	Homo sapiens	48-51	
28928082-1	2017	Evidence demonstrate that p53 mutations and microRNAs (miRs) are important components of 5-FU resistance in colorectal cancer (CRC).	Fluorouracil	89-93	tumor protein p53	Homo sapiens	26-29	
28928082-8	2017	Moreover, inhibition of miR-338-3p in HT29 and HCT116 p53-/- cells increased their sensitivity to 5-FU treatment.	Fluorouracil	98-102	tumor protein p53	Homo sapiens	54-57	
28928082-10	2017	Our results reveal a critical and novel role of miR-338-3p in the correlation of 5-FU resistance with p53 status.	Fluorouracil	81-85	tumor protein p53	Homo sapiens	102-105	
28928082-11	2017	Moreover, the miR-338-3p inhibitor has the potential to overcome 5-FU resistance in p53 mutant colon cancer cells.	Fluorouracil	65-69	tumor protein p53	Homo sapiens	84-87